Bina R Ghatalia's Insider Trades & SAST Disclosures

Bina R Ghatalia's most recent trade in Aarey Drugs & Pharmaceuticals Ltd. was a Acquisition of 500,000 Equity Shares done at an average price of Rs. 32 . Disclosure was reported to the exchange on June 23, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.

No reported SAST transactions available for Bina R Ghatalia in the Trendlyne database.

Stock Client Name Client Category Action* Reported To/By Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Period Regulation (Insider/SAST) Security Type Mode
Aarey Drugs & Pharma
Bina Rajesh Ghatalia Promoter Acquisition 23 Jun 2022 500,000 4,000,834 (15.76%) 1.97% 32 16,000,000 23 Jun 2022
23 Jun 2022
Insider Trading Equity Shares Off Market
Aarey Drugs & Pharma
Bina Rajesh Ghatalia Promoter Acquisition 14 Dec 2021 150,000 3,500,834 (13.79%) 0.64% 41.2 6,174,000 25 Nov 2021
25 Nov 2021
Insider Trading Equity Shares Allotment
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal. 
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal. 
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.
View All The Insider Trades & SAST